3.3. Primary and Secondary Outcomes
TG
NMS
The baseline values of biomarkers and CIMT were comparable between the two groups. In the NMS group, significant improvements in all lipid outcomes were observed at both the 45-day and 120-day marks. Conversely, in the placebo group, only TC, TG, non-HDL-C, and the LDL-C to HDL-C ratio showed significant improvements at both time points (as shown in 